NLS Pharma (Equity)
Funding Details
Date Award
May 17, 2025
Vertical
Biopharma
Funding URL
View Funding Page
Funding Amount
$3,000,000
Company Info
Market
Regenerative Medicine and CNS Disorders
Location
Zurich, Switzerland
Company Description

NLS Pharma is focused on developing therapies for ALS and type 1 diabetes, leveraging a merger with Kadimastem to enhance its capabilities in regenerative medicine and CNS disorders.

Links
Back to HomeBack to Biopharma DealsView Funding Announcement